Form
Approved
OMB No. 0935-XXXX
Exp. Date XX/XX/20XX
Agency
for Healthcare Research and Quality
Evaluation
of the National Guideline Clearinghouse™
Survey
Questionnaire
Public
reporting burden for this collection of information is estimated to
average 8
minutes per response, the estimated time required to complete
the survey. An agency may not conduct or sponsor, and a person
is not required to respond to, a collection of information unless it
displays a currently valid OMB control number. Send
comments regarding this burden estimate or any other aspect of
this collection of information, including suggestions for reducing
this burden, to: AHRQ Reports Clearance Officer Attention: PRA,
Paperwork Reduction Project (0935-XXXX) AHRQ,
540 Gaither Road, Room # 5036, Rockville, MD 20850.
Figure 1: Schematic of the NGC Evaluation Survey Branch Pattern
Section 1 – NGC Awareness Screening |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Measurement Scale |
Skip Pattern |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ Yes □ No |
If
“YES”, skip to Section 2A
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section 2A – Use of NGC (AWARE OF NGC; “yes” to question 1) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Measurement Scale |
Skip Pattern |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ Yes □ No |
If
“YES”, move to section 3
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section 2B – Respondent Characteristics and Use of Clinical Practice Guidelines (UNAWARE OF NGC; “NO” to question 1, section 1 OR AWARE OF NGC but have never used the NGC Web site; Answered “NO” to question 2, section 2B) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Measurement Scale |
Skip Pattern |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ United States Northeast Region (Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, Pennsylvania) □ United States Midwest Region (Ohio, Indiana, Illinois, Michigan, Wisconsin, Minnesota, Iowa, Missouri, North Dakota, South Dakota, Nebraska, Kansas) □ United States South Region (Delaware, Maryland, District of Columbia, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, Oklahoma, Texas) □ United States West Region (Montana, Idaho, Wyoming, Colorado, New Mexico, Arizona, Utah, Nevada, Washington, Oregon, California, Alaska, Hawaii) □ Canada □ Latin America □ Europe □ Africa □ Asia □ Australia/New Zealand □ Other |
Go to question 3 (2B) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ Physician □ Physician Assistant □ Nurse/Nurse Practitioner □ Pharmacist □ Dentist □ Other Clinical Specialist □ Hospital/Health Plan Administrator □ Health Care Consultant □ Health Services/Clinical Researcher □ Guideline Developer □ Measure Developer □ Health Care Purchaser/Employer □ Health Care Provider □ Federal/State/Government Policymaker □ Legal Professional □ Informatician/informatics specialist □ Medical Librarian/Info Specialist □ Medical Writer/Editor □ Medical Student □ Nursing Student □ Pharmacy Student □ Other Student □ Patient/Consumer □ Quality Manager/Specialist □ Other: Please Specify |
Go to question 4 (2B) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ Very Frequently □ Frequently □ Occasionally □ Rarely □ Very Rarely □ Never |
If NEVER, go to question 6 (2B) If anything other than NEVER, go to question 5 (2B) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ Pubmed/Medline □ From a search using a general purpose Web search engine (e.g., Google) □ Point-of-care Web-based resources (e.g., DynaMed, Essential Evidence Plus, EMedicine) □ Medscape □ U.S. Preventive Services Task Force □ National Institute for Health and Clinical Excellence (NICE) □ Guidelines Advisory Committee (Canada) □ Guidelines International Network (G-I-N) □ Institute for Clinical Systems Improvement (ICSI) □ Colorado Clinical Guidelines Collaborative (CCGC) □ Milliman Care Guidelines® □ Expert Consensus Guidelines® (EKS®) □ Medical Specialty Society guidelines (e.g.,AACE, AAFP, AAN, AAO, AAOS, AAP, ACC, ACCP, ACEP, ACP, ACPM, ACR, AGA, ASCO, ASGE, IDSA, SAGES) □ Professional or Disease Specific Society guidelines (e.g., AASM, AARC, ACS, ADA, AHA, ASPEN, BTF, HFSA, NKF, SCCM) □ Government guidelines (e.g., CDC, NHLBI, SAMHSA, TFCPS, DoD/VHA) □Commercial products (e.g., UpToDate; ACP Pier) (please specify) □ Other government entities □ Other [free text option] |
Go to question 6 (2B) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ Yes □ No |
Complete survey and provide link to NGC for interested respondents |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section 3 – Respondent Characteristics, Use of Clinical Guidelines, and Use of NGC (AWARE OF NGC and have used the NGC Web site) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Measurement Scale Skip Pattern |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ United States Northeast Region (Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, Pennsylvania) □ United States Midwest Region (Ohio, Indiana, Illinois, Michigan, Wisconsin, Minnesota, Iowa, Missouri, North Dakota, South Dakota, Nebraska, Kansas) □ United States South Region (Delaware, Maryland, District of Columbia, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, Oklahoma, Texas) □ United States West Region (Montana, Idaho, Wyoming, Colorado, New Mexico, Arizona, Utah, Nevada, Washington, Oregon, California, Alaska, Hawaii) □ Canada □ Latin America □ Europe □ Africa □ Asia □ Australia/New Zealand □ Other |
Go to question 4 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ Physician □ Physician Assistant □ Nurse/Nurse Practitioner □ Pharmacist □ Dentist □ Other Clinical Specialist □ Hospital/Health Plan Administrator □ Health Care Consultant □ Health Services/Clinical Researcher □ Guideline Developer □ Measure Developer □ Health Care Purchaser/Employer □ Health Care Provider □ Federal/State/Government Policymaker □ Legal Professional □ Informatician/informatics specialist □ Medical Librarian/Info Specialist □ Medical Writer/Editor □ Medical Student □ Nursing Student □ Pharmacy Student □ Other Student □ Patient/Consumer □ Quality Manager/Specialist □ Other: Please Specify |
Go to question 5 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
How long have you been using the NGC web site? |
□ Less than 12 months □ 1 to 2 years □ >2 to 3 years □ >3 to 4 years □ >4 to 5 years □ More than 5 years |
Go to question 6 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ 0 times □ 1-10 times □ 11-25 times □ 26-50 times □ 50+ times |
If
“0 times”, go to question 7 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
If you have not visited the NGC in the past 12 months, why not?
|
□ No need to locate clinical guideline information □ Needed the information, but went without it □ Needed the information, but used other guideline source instead of NGC □ Other, please specify: ________________________________ |
Go to question 8 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ General purpose Web search engine (e.g., Google, Yahoo, etc.) □ AHRQ Web site □ Link from another health-related Web site □ Print media □ Word of mouth, or from a colleague or friend □ Do not recall □ Other, please specify________________ |
Go to question 9 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ Pubmed/Medline □ From a search using a general purpose Web search engine (e.g., Google) □ Point-of-care Web-based resources (e.g., DynaMed, Essential Evidence Plus, EMedicine) □ Medscape □ U.S. Preventive Services Task Force □ National Institute for Health and Clinical Excellence (NICE) □ Guidelines Advisory Committee (Canada) □ Guidelines International Network (G-I-N) □ Institute for Clinical Systems Improvement (ICSI) □ Colorado Clinical Guidelines Collaborative (CCGC) □ Milliman Care Guidelines® □ Expert Consensus Guidelines® (EKS®) □ Medical Specialty Society guidelines (e.g.,AACE, AAFP, AAN, AAO, AAOS, AAP, ACC, ACCP, ACEP, ACP, ACPM, ACR, AGA, ASCO, ASGE, IDSA, SAGES) □ Professional or Disease Specific Society guidelines (e.g., AASM, AARC, ACS, ADA, AHA, ASPEN, BTF, HFSA, NKF, SCCM) □ Government guidelines (e.g., CDC, NHLBI, SAMHSA, TFCPS, DoD/VHA) □Commercial products (e.g., UpToDate; ACP Pier) (please specify) □ Other government entities □ Other [free text option] |
Go to question 10 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
□ Much less satisfied with NGC □ Slightly less satisfied with NGC □ Satisfaction about equal □ Slightly more satisfied with NGC □ Much more satisfied with NGC |
Go to question 11 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 |
Please indicate the degree to which use of the NGC Web site fulfills your needs for each of the following tasks: |
|
Go to question 12 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 |
Please indicate the degree to which use of OTHER GUIDELINE SOURCES (other than NGC) fulfill your needs for each of the following tasks: |
|
Go to question 13 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 |
How would you rate the trustworthiness of the guidelines included in NGC? |
□ Very poor □ Poor □ Acceptable □ Good □ Very good □ Don’t know |
Go to question 14 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 |
How would you rate NGC’s guideline inclusion criteria {will include alt text to define NGC inclusion criteria} |
□ Stringent □ Loose □ Appropriate □ Don’t know |
Go to question 15 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 |
NGC’s current inclusion criteria require that guidelines included on the Web site have been reviewed, revised, or developed within the last five years. How would you rate this timeframe? |
□ Too long (should be reduced to 4 years) □ Too long (should be reduced to 3 years) □ Too long (should be reduced to 2 years) □ Too short (should be lengthened) □ Appropriate □ Don’t know |
Go to question 16 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 |
How likely would you be to use any of the following enhancements to the NGC Web site |
|
Go to question 17 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 |
How likely are you to continue using the NGC Web site? |
□ Definitely □ Very likely □ Probably □ Possibly □ Probably not □ Definitely not □ Don’t know |
Go to question 18 (3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 |
How likely are you to recommend the NGC Web site to your colleagues? |
□ Definitely □ Very likely □ Probably □ Possibly □ Probably not □ Definitely not □ Don’t know |
Go to the introduction to Section 4 which allows users to select the most appropriate questions to answer. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SECTION 4: The last section of this survey provides more focused questions depending on your primary use of the site. Please select the topic area that best reflects your primary role when using NGC. If you would like to answer questions for more than one topic area, you will have an opportunity to do so after you complete the section.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guideline
|
Physician |
Medical |
Informatics
|
Researcher |
Healthcare
Purchaser, |
Measure Developer |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
# |
Question |
Measurement Scale |
Skip Pattern |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section 4 Respondent-Specific [GUIDELINE DEVELOPER (GD)] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 |
Do you (or your organization) submit guidelines for inclusion in the National Guideline Clearinghouse (NGC)? |
□ Yes □ No □ Don’t know |
If NO or Don’t Know, go to question 22 (GD) If YES, go to question 20 (GD) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 |
If “Yes”, in your experience, how would you rate each of the following components of the NGC process: |
|
Go to question 21 (GD)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 |
Please indicate how your organization uses the annual, NGC Summary usage reports (which identify how many times your organization's guidelines have been accessed on the NGC Web site) that it receives during NGC's Annual Verification? |
□ As an indirect measure of the dissemination of your organization's guidelines? □ Research/agenda priority setting? □ Budget justification □ Don't know □ This information is not used at all Other, PLEASE SPECIFY |
Go to question 22 (GD)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 |
Has NGC influenced any of the following components of your organization’s guideline development program: |
|
Go to question 23 (GD)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 |
Does your organization create implementation tools that can be used to facilitate implementation of your organizations guidelines? |
□ Always □ Occasionally □ Rarely □ Never □ Don’t know |
Go to question 24 (GD) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 |
Does your organization create quality measures that can be used to assess the implementation of your organization's guidelines? |
□ Always □ Occasionally □ Rarely □ Never □ Don’t know |
Go to question 25 (GD) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 |
Does your organization develop guidelines in a format that can be integrated into electronic medical records or other clinical decision support tools? |
□ Always □ Occasionally □ Rarely □ Never □ Don’t know |
Go to question 26 (GD) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26 |
If you answered always, occasionally, or rarely to any of the three preceding questions, has NGC had an influence on any of the following: |
|
Go to question 27 (GD) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27 |
Does your organization use any of the following AHRQ-sponsored products to inform its guideline development activities? Check all that apply |
□ Systematic evidence reviews □ Technology assessments □ Comparative effectiveness reviews □ Technical briefs □ Policymaker guides □ DEcIDE project reports □ CERT project reports □ Other products from AHRQ’s Effective Health Care Program □ Other [Please specify] |
Provide links to other Section 4 survey options; If respondent choose to end survey, go to last question before exiting. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thank you for participating in this evaluation of the National Guideline Clearinghouse. If you would like to contribute additional input, please select the most relevant feedback category: Physician, Nurse, Other Healthcare Provider, Student Medical Librarian Informatics Specialist Researcher Healthcare
Purchaser, Policymaker, Other Click here to Complete Survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LAST Question: Have you taken this NGC Evaluation Survey within the Past 4 weeks? |
□ Yes □ No □ Don’t know |
Exit survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section 4 Respondent-Specific [PHYSICIANS, NURSE, OTHER HEALTHCARE PROVIDER/STUDENT (PNOHP)] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
# |
Question |
Measurement Scale |
Skip Pattern |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 |
Has NGC influenced any of the follow: |
|
Go to question 20 (PNOHP) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 |
Do you or your organization utilize electronic medical records? |
□ Yes □ No □ Don’t know |
Go to question 21 (PNOHP) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 |
Do you or your organization utilize clinical decision support tools at the point of care? |
□ To a Great Extent □ Somewhat □ Very Little □ Not at All □ Don’t know |
If YES, go to question 22 (PNOHP) If NO, go to question 23 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 |
Would having content from the NGC Web site delivered to you at the point of care be useful to you?
|
□ To a Great Extent □ Somewhat □ Very Little □ Not at All □ Don’t know |
Go to question 23 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 |
Is there a need to broaden the scope and type of guidelines (e.g., credentialing, privileging, ethical, procedural, training) included in NGC? |
□ Strongly Agree □ Agree □ Undecided □ Disagree □ Strongly Disagree □ Don’t know |
Go to question 24 (PNOHP) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 |
If continuing medical educations were available through NGC would you take advantage of it?: |
|
Provide links to other Section 4 survey options; If respondent choose to end survey, go to last question before exiting. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thank you for participating in this evaluation of the National Guideline Clearinghouse. If you would like to contribute additional input, please select the most relevant feedback category: Guideline Developer Medical Librarian Informatics Specialist Researcher Healthcare
Purchaser, Policymaker, Other Click here to Complete Survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LAST Question: Have you taken this NGC Evaluation Survey within the Past 4 weeks? |
□ Yes □ No □ Don’t know |
Exit survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section 4 Respondent-Specific [MEDICAL LIBRARIAN (ML)] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Measurement Scale |
Skip Pattern |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 |
Has NGC influenced any of the follow: |
|
Go to question 20 (ML) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 |
NGC currently uses the UMLS Metathesaurus to index the guideline summary content included on the site to support browsing and searching. Should NGC use other controlled medical vocabularies for this purpose? |
□ Yes □ No □ Don’t know □ If Yes, Please specify_________________ |
Provide links to other Section 4 survey options; If respondent choose to end survey, go to last question before exiting. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thank you for participating in this evaluation of the National Guideline Clearinghouse. If you would like to contribute additional input, please select the most relevant feedback category: Guideline Developer Physician, Nurse, Other Healthcare Provider, Student Researcher Informatics Specialist Healthcare
Purchaser, Policymaker, Other Click here to Complete Survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LAST Question: Have you taken this NGC Evaluation Survey within the Past 4 weeks? |
□ Yes □ No □ Don’t know |
Exit survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section 4 Respondent-Specific [RESEARCHER (RS)] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Measurement Scale |
Skip Pattern |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 |
Has NGC influenced any of the follow: |
|
Go to question 20 (RS) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 |
Do you use any of the following AHRQ-sponsored products in your research efforts? Check all that apply |
Products from AHRQ’s Effective Health Care Program □ Systematic evidence reviews □ Technology assessments □ Comparative effectiveness reviews □ Technical briefs □ Policymaker guides □ DEcIDE project reports □ CERT project reports AHRQ Databases or Survey Data □ MEPS: Medical Expenditure Panel Survey □ HCUP: Healthcare Cost & Utilization Project □ HCUPnet: Interactive Tool for Hospital Statistics □ Other [Please specify] |
Provide links to other Section 4 survey options; If respondent choose to end survey, go to last question before exiting. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thank you for participating in this evaluation of the National Guideline Clearinghouse. If you would like to contribute additional input, please select the most relevant feedback category: Guideline Developer Physician, Nurse, Other Healthcare Provider, Student Medical Librarian Informatics Specialist Healthcare
Purchaser, Policymaker, Other Click here to Complete Survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LAST Question: Have you taken this NGC Evaluation Survey within the Past 4 weeks? |
□ Yes □ No □ Don’t know |
Exit survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section 4 Respondent-Specific [INFORMATICS SPECIALIST (IS)] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Measurement Scale |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 |
Do you currently USE or DEVELOP Web 2.0 applications (e.g., blogs, wikis. RSS) to communicate about NGC guidelines? |
□ To a Great Extent □ Somewhat □ Very Little □ Not at All □ Don’t know |
Go to question 20 (IS) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 |
Do you utilize NGC data as an input in developing clinical information or decision support systems? |
□ To a Great Extent □ Somewhat □ Very Little □ Not at All □ Don’t know |
Go to question 21 IRS) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 |
If you utilize NGC data to develop clinical information or decision support system, what type of data and what type of Application Programming Interface (API) would you like NGC to provide? (For example, structured interface for search query and xml output for search results) |
Free Text |
Go to question 22 IRS) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 |
Do you utilize any of NGC’s current RSS downloads? |
|
Go to question 23 (IS) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 |
Do you utilize the NGC Search Form Feature which allows developers to create search interfaces with NGC on external sites? |
□ To a Great Extent □ Somewhat □ Very Little □ Not at All □ Don’t know |
Go to question 24(IS) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 |
Would having an NGC output for individual guidelines available as an XML file according to the Guideline Elements Model (GEM) be useful to you in your work? |
□ To a Great Extent □ Somewhat □ Very Little □ Not at All |
Provide links to other Section 4 survey options; If respondent choose to end survey, go to last question before exiting. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thank you for participating in this evaluation of the National Guideline Clearinghouse. If you would like to contribute additional input, please select the most relevant feedback category: Guideline Developer Physician, Nurse, Other Healthcare Provider, Student Medical Librarian Researcher Healthcare
Purchaser, Policymaker, Other Click here to Complete Survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LAST Question: Have you taken this NGC Evaluation Survey within the Past 4 weeks? |
□ Yes □ No □ Don’t know |
Exit survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section 4 Respondent-Specific [Healthcare Purchaser, Policymaker, Other (HPPO)] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
# |
Question |
Measurement Scale |
Skip Pattern |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 |
Has NGC influenced any of the follow: |
|
Go to question 20 (HPPO) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 |
Does your organization use any other the following AHRQ-sponsored products to inform its policy decision making? Check all that apply |
□ Systematic evidence reviews □ Technology assessments □ Comparative effectiveness reviews □ Technical briefs □ Policymaker guides □ DEcIDE project reports □ CERT project reports □ Other products from AHRQ’s Effective Health Care Program □ Other [Please specify] |
Provide links to other Section 4 survey options; If respondent choose to end survey, go to last question before exiting. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thank you for participating in this evaluation of the National Guideline Clearinghouse. If you would like to contribute additional input, please select the most relevant feedback category: Guideline Developer Physician, Nurse, Other Healthcare Provider, Student Medical Librarian Researcher Informatics
Specialist Click here to Complete Survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LAST Question: Have you taken this NGC Evaluation Survey within the Past 4 weeks? |
□ Yes □ No □ Don’t know |
Exit survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section 4 Respondent-Specific [Measure Developer (MD)] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
# |
Question |
Measurement Scale |
Skip Pattern |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 |
Has NGC had an influence on any of the following: |
|
Go to question 20 (MD) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 |
Does your organization use NGC as an input for its measure development activities? |
□ To a Great Extent □ Somewhat □ Very Little □ Not at All |
Go to question 21 (MD) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 |
Does your organization submit its measures to AHRQ’s National Quality Measures Clearinghouse™ (NQMC) |
□Yes □ No □ Don’t know |
Provide links to other Section 4 survey options; If respondent choose to end survey, go to last question before exiting. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thank you for participating in this evaluation of the National Guideline Clearinghouse. If you would like to contribute additional input, please select the most relevant feedback category: Guideline Developer Physician, Nurse, Other Healthcare Provider, Student Medical Librarian Researcher Informatics Specialist Healthcare Purchaser, Policymaker, Other Click here to Complete Survey |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LAST Question: Have you taken this NGC Evaluation Survey within the Past 4 weeks? |
□ Yes □ No □ Don’t know |
Exit survey |
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | Survey Instrument |
Author | Michelle Tregear |
File Modified | 0000-00-00 |
File Created | 2021-02-01 |